Navigation Links
The CAI, NIH & NCI Partnership: The NCI Invention Portfolio for High Commercial Potential Based on CAI’s Proprietary and Rigorous Business Market and Scientific Criteria
Date:8/1/2013

Bethesda, Maryland (PRWEB) August 01, 2013

The Center for Advancing Innovation, INC (CAI), a globally focused private-public partnership with an over-arching mission to drive successful innovation entered into a Partnership Intermediary Agreement (PIA) with the National Institutes of Health’s (NIH) Office of Technology Transfer (OTT) and the National Cancer Institute (NCI) Technology Transfer Center (TTC).

As a partnership intermediary for NIH OTT and the NCI, the team from CAI, which includes over 20 Ph.D.s, MBAs and other analysts, is assisting the NCI and NIH to accelerate the commercialization of NCI technologies. Using CAI’s robust and unique portfolio assessment model, the partners are working together to evaluate the NCI patent portfolio consisting of thousands of NCI intramural technologies in the areas of drugs, vaccines, therapeutics, diagnostics and medical devices. Through this assessment model, CAI, NCI and NIH have worked together to identify those inventions anticipated to have significant impact on the public health. Recently we reached a significant milestone, as we have identified the top 50 near-term, commercially viable inventions. CAI will also coordinate interest with small businesses, the biopharmaceutical industry and educational institutions to match NCI technologies for possible collaboration and transfer for commercialization.

According to Tom Stackhouse, Associate Director of the Technology Transfer Center at NCI, the NCI TTC and NIH OTT will be working with CAI to accelerate and increase the volume of commercial development and licensing of innovative technologies coming from the NCI and NIH intramural research programs. He also noted that NCI is already seeing the benefit from this partnership via several new opportunities between potential licensees, collaboration partners and NIH inventors.

“CAI’s partnership with the NIH and NCI is an ideal foundation to commercialize intramural inventions and make a sustainable impact on world health and the nation’s economy,” said Rosemarie Truman, CAI Founder and CEO. “We’re strongly encouraged about our collective team’s progress and we are in the process of engaging economic development organizations, entrepreneurs, foundations, large pharmas and other organizations as potential partners to perform additional R&D with the NCI labs.”

The most exciting phase of this new partnership is developing new models for moving technology from the NCI labs to the commercial sector. Stay tuned for upcoming news about this partnership’s plans to launch a new and exciting commercialization event.

About The Center for Advancing Innovation (CAI)

The Center for Advancing Innovation is global innovation intermediary focused on commercializing market viable innovations, increasing the success of startups and entrepreneurship and making an economic impact with these efforts. CAI focuses on all industries; at present, the focus is biotechnology, biopharma, medical devices, healthcare services, Health IT, e-health, mobile health, electronic medical records, health informatics, biohealth cyber security, high tech as well as internet/social media type inventions. For more information, please visit http://www.thecenterforadvancinginnovation.org.

About the NIH Office of Technology Transfer (NIH OTT)

OTT manages the patenting and licensing of a wide range of inventions made by scientists working for the NIH and FDA intramural research programs as mandated by the Federal Technology Transfer Act and related legislation. OTT also facilitates access to NIH and FDA inventions by developing research relationships between NIH and FDA intramural scientists with researchers in businesses and higher educational institutions. More information can be found at http://www.ott.nih.gov.

About the NCI Technology Transfer Center (NCI TTC)

NCI TTC serves as the Institute’s focal point for implementation of the Federal Technology Transfer Act by working closely with NCI investigators and outside parties to facilitate commercialization efforts to benefit public health. In this role it manages the NCI patent portfolio and utilizes these patents as incentive for commercial development of technologies, and establishes formal collaborative R&D partnerships among academia, federal laboratories, and industry.

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.

Read the full story at http://www.prweb.com/releases/2013/8/prweb10981539.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Block O'Toole & Murphy, LLP Personal Injury Trial Lawyers Take $2,270,000 Verdict In Brooklyn Motor Vehicle Accident Case
2. H&HN Takes Home Another ‘Magazine of the Year’ Award
3. Diet Doc Weight Loss Diets & Weight Loss Plans Announces Refurbished Medical Diet Plans Designed to Melt Pounds and Inches Without Strenuous Exercise Regimens
4. Gloria Rand - SEO Copywriter Joins Team in Training in Orlando, FL to Raise Money for Fight against Leukemia & Lymphoma
5. Specialty Drug Delivery Firm Integral BioSystems LLC to Participate in Contract Pharma Magazine’s 12th Annual Contracting & Outsourcing Conference & Tabletop Exhibition
6. Scott Sheldon – Specialist in Healthcare and Life Sciences Supply Chain & Official Sponsor of LogiPharma 2013
7. Augmented Reality & Virtual Reality Market is Growing at a CAGR of 15.18% & will Reach 1.06 Billion by 2018 - New Report by MarketsandMarkets
8. Spectrum Surgical Offers Veterinary Gold-Handled Needle Holder Repair & Refurbishing Services
9. International Fitness Celebrity Jennifer Nicole Lee Will Be Featured as a Top Presenter & Group Instructor at the World Famous Fitness Celebrity Festival Sweat Miami
10. Diet Doc Weight Loss Diets & Diet Plans Announces New, Satisfying Healthy Food Recipes and Clean Eating Diets that Reduce Body Fat without Uncontrollable Hunger
11. Embedded IC & Die Technologies Patent Market Analysis & Survey Report Now Available at ReportsnReports.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... ... ... Delaware farmer Rick Dickerson attended the 2017 Soybean Leadership College ... a thousand acres of soybeans, corn and wheat, and raises peas, sweet corn, baby ... for the fresh market. He also operates a roadside stand and raises broilers for ...
(Date:1/18/2017)... USA; SAN JOSE, Calif, USA; and SHANGHAI, China – , ... ... (PRWEB) January 18, 2017 -- Global public health organization NSF ... arsenic V (pentavalent arsenic) to NSF/ANSI 53: Drinking Water Treatment ... water treatment units. This certification verifies that MicroCeramics’ NanoNose Pitcher ...
(Date:1/18/2017)... ... January 18, 2017 , ... PrideStaff, a national, ... of Franchise Development, Paula Turner Pizarro, was recently featured on Fox Business Network's ... insights of top business leaders from across the globe, provides viewers an opportunity ...
(Date:1/18/2017)... Alexandria, VA (PRWEB) , ... January 18, 2017 , ... ... services in family, cosmetic and implants dentistry. His modern dental practice has two convenient ... Qureshi as a 2017 Top Rated Dentist for the Alexandria area. This ...
(Date:1/18/2017)... ... January 18, 2017 , ... Rollerblade®, ... Brake Technology (ABT), an innovative braking system that allows skaters of all levels ... one of the biggest concerns of beginner and intermediate skaters – learning how ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... SHANGHAI , Jan. 18, 2017 In ... of revolution, which is where the Upgrade of ... year of the 13th Five-Year Plan for Economic and Social ... (the 13th Five-Year Plan), and the state council of ... the "13th Five-Year" national strategic emerging industry development plan, identifying ...
(Date:1/18/2017)... , January 18, 2017 Ximbio, ... to share research resources, has opened its first North American ... ... marks an expansion for Ximbio following its launch in October ... Research Technology (CRT), the commercialization arm of the foundation Cancer ...
(Date:1/18/2017)... Authority Chinese Food and Drug Administration CSL ... Institute Food and Drug Administration FORT ... Glaxo Smith Klein GlaxoWellcome Global Influenza ... Immune Targeting Systems Indian Association of ... Johnson & Johnson Krka Pharmaceuticals Medicago ...
Breaking Medicine Technology: